This case places the reader in the position of chief executive officer of a global pharmaceutical company facing a difficult decision. The scenario presented is reflective of an actual decision made by a global healthcare company based in the United States. The company’s research and development team believes it may have discovered the cure for a horrible illness afflicting millions of the world’s poorest people. The company’s leadership must make a decision to either pursue the drug, which future patients would be unable to pay for, or decline to pursue it based largely on economic grounds. The decision is further complicated by the company’s poor recent financial performance. The information provided in the case related to the company’s stock price performance is identical to what the company faced as it made this decision. In addition, the mission and core values provided in the case are closely based upon the company’s own. The company’s name and individuals’ names presented in the case are fictional.